Mascual, Romeo D.

HRN: 29-33-08  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/15/2026
07/21/2026
IV
600mg
Q6
Dm Foot
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: